Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
环境 Ah 受体配体对宿主微生物组代谢轴的影响
基本信息
- 批准号:9982685
- 负责人:
- 金额:$ 34.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:16S ribosomal RNA sequencingAddressAdultAlbuminsAroclor 1254Aryl Hydrocarbon ReceptorAutomobile DrivingBioinformaticsBiologyCeramidesConsultDataDependenceDevelopmentDietDioxinsDisease OutcomeDoseElectrophoretic Mobility Shift AssayEnvironmental PollutantsEnvironmental PollutionExperimental DesignsExposure toFatty LiverFutureGenesGenomicsGerm-FreeGnotobioticHepaticHumanInflammationInflammatoryIntestinesKnock-outLCN2 geneLigandsLinkLiverMeasurementMediatingMetabolicMetabolic DiseasesMetagenomicsMolecular ToxicologyMusObesityPathogenesisPathway interactionsPolychlorinated BiphenylsPopulationPredispositionProductionPublicationsReceptor ActivationRepressionResearchResearch PersonnelRoleSequence AnalysisSpecificityStructureTechniquesTetrachlorodibenzodioxinTimeTissuesToxicologyWeaningaryl hydrocarbon receptor ligandbacterial communitychromatin immunoprecipitationconditional knockoutcytokineexperimental studyflexibilitygut microbiomegut microbiotahost microbiomeinnovationinsightinterestlipid biosynthesisliver developmentmetabolic phenotypemetabolomicsmicrobiomemid-career facultymouse modelnon-alcoholic fatty liver diseasenovelprogramsrRNA Genesresponsevillin
项目摘要
ABSTRACT
The aryl hydrocarbon receptor (AHR) modulates the host-microbiome metabolic axis. There are strong links
between the gut microbiota and the development and/or exacerbation of nonalcoholic fatty liver disease
(NAFLD), all of which are modulated by activation or repression of the AHR. A mechanistic connection
between AHR activation, changes in gut microbiota composition/function, and NAFLD development has not
been established. Further, the concept that environmental pollutant-mediated disruption and/or modulation of
the AHR-gut microbiota metabolic axis leads to the development of NAFLD has not been addressed. Our
published4-7 and preliminary data with 2,3,7,8-tetrachlorodibenzofuran (TCDF) indicates AHR activation
profoundly alters the gut microbiota in a qualitative and quantitative manner, increases hepatic lipogenesis,
significantly alters hepatic ceramide synthesis through direct AHR activity (a proposed driver of NAFLD), and
increases systemic inflammation. These results have led to the novel central hypothesis: Dietary exposure to
potent environmental AHR ligands leads to functionally significant changes in the gut microbiota that
exacerbate NAFLD in a time- and Ahr-dependent manner.
Through the innovative use of cutting-edge techniques (16S rRNA gene sequencing, metagenomics and
metabolomics) and unique mouse models (tissue specific knockouts of Ahr, gnotobiotic mice, and fecal
transfer experiments), we plan to identify the functional changes imparted to the gut microbiota following
dietary exposure to potent AHR ligands such as TCDF and to evaluate the AHR-dependent role of ceramides
in driving NAFLD pathogenesis and progression. This combination of approaches will allow us to accurately
assess bacterial community dynamics and its interaction with and impact on the host, and whether these
changes result in increased susceptibility to NAFLD. We are particularly interested in how the timing (weaning,
adulthood) of the exposure influences disease outcome. This study will provide new insight into the effects of
exposure on a number of environmentally relevant persistent AHR ligands, such as 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) and co-planar PCBs (PCB-126) and provide valuable endpoints for future studies in human
populations.
摘要
芳烃受体(AHR)调节宿主-微生物组的代谢轴。有很强的联系
肠道微生物区系与非酒精性脂肪性肝病的发生和/或加重之间的关系
(NAFLD),所有这些都通过激活或抑制AHR来调节。机械连接
在AHR激活、肠道微生物区系组成/功能改变和NAFLD发展之间没有
已经建立了。此外,环境污染物介导的干扰和/或调节的概念
AHR-肠道微生物区系代谢轴导致NAFLD的发展尚未得到解决。我们的
发表的4-7和2,3,7,8-四氯二苯并呋喃(TCDF)的初步数据表明AHR激活
从质和量上深刻改变肠道微生物区系,增加肝脏脂肪生成,
通过直接AHR活性显著改变肝脏神经酰胺的合成(NAFLD的一个拟议驱动因素),以及
增加全身炎症。这些结果导致了新的中心假说:饮食暴露于
强有力的环境AHR配体导致肠道微生物区系功能上的重大变化,
以时间和时间依赖的方式加重非酒精性脂肪肝。
通过创新地使用尖端技术(16S rRNA基因测序、元基因组学和
代谢组学)和独特的小鼠模型(AhR、诺生菌小鼠和粪便的组织特异性敲除
转移实验),我们计划确定以下给肠道微生物区系带来的功能变化
膳食暴露于TCDF等强有力的AHR配体,并评估神经酰胺对AHR的依赖作用
在推动非酒精性脂肪性肝病的发病和进展中起重要作用。这种方法的组合将使我们能够准确地
评估细菌群落动态及其与宿主的相互作用和影响,以及这些
这些变化导致对NAFLD的易感性增加。我们特别感兴趣的是时间(断奶,
成年期)的暴露会影响疾病的结局。这项研究将为我们提供新的视角来了解
暴露在一些与环境有关的持久性AHR配体上,如2,3,7,8-四氯二苯并-2,3,7,8-四氯二苯并
P-二恶英(TCDD)和共面多氯联苯(PCB-126),并为未来的人类研究提供有价值的终点
人口。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Patterson其他文献
Andrew Patterson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Patterson', 18)}}的其他基金
Environmental Chemical Impact on the Host-Microbiome Interaction
环境化学对宿主-微生物组相互作用的影响
- 批准号:
10641509 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training Program
代谢表型综合分析(IAMP)博士前培训项目
- 批准号:
10417044 - 财政年份:2020
- 资助金额:
$ 34.6万 - 项目类别:
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training Program
代谢表型综合分析(IAMP)博士前培训项目
- 批准号:
10626745 - 财政年份:2020
- 资助金额:
$ 34.6万 - 项目类别:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
癌症预防和治疗中 PPARβ/β 调节的独特靶向
- 批准号:
10066327 - 财政年份:2019
- 资助金额:
$ 34.6万 - 项目类别:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
癌症预防和治疗中 PPARβ/β 调节的独特靶向
- 批准号:
10311068 - 财政年份:2019
- 资助金额:
$ 34.6万 - 项目类别:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
R01:FXR 和肠道微生物组作为非酒精性脂肪肝的调节剂
- 批准号:
10228735 - 财政年份:2019
- 资助金额:
$ 34.6万 - 项目类别:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
癌症预防和治疗中 PPARβ/β 调节的独特靶向
- 批准号:
10539245 - 财政年份:2019
- 资助金额:
$ 34.6万 - 项目类别:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
癌症预防和治疗中 PPARβ/β 调节的独特靶向
- 批准号:
9906573 - 财政年份:2019
- 资助金额:
$ 34.6万 - 项目类别:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
R01:FXR 和肠道微生物组作为非酒精性脂肪肝的调节剂
- 批准号:
10488612 - 财政年份:2019
- 资助金额:
$ 34.6万 - 项目类别:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
R01:FXR 和肠道微生物组作为非酒精性脂肪肝的调节剂
- 批准号:
10671560 - 财政年份:2019
- 资助金额:
$ 34.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.6万 - 项目类别:
Research Grant